Helen Thackray

Technik-/Wissenschafts-/F&E-Leiter bei BIOCRYST PHARMACEUTICALS, INC.

Vermögen: 1 Mio $ am 30.04.2024

55 Jahre

Health Technology

Consumer Services

Government

Aktive Positionen von Helen Thackray

Unternehmen	Position	Beginn	Ende
BIOCRYST PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	19.03.2021	-
	Direktor/Vorstandsmitglied	20.09.2019	19.03.2021
	Independent Dir/Board Member	20.09.2019	19.03.2021
Holy Cross Hospital (Maryland)	Corporate Officer/Principal	-	-
Gw School of Medicine & Health Sciences	Corporate Officer/Principal	01.01.2000	-

Unternehmen	Position	Beginn	Ende
IMMUNOGEN, INC.	Direktor/Vorstandsmitglied	22.09.2021	12.02.2024
IMMUNOGEN, INC.	Independent Dir/Board Member	22.09.2021	12.02.2024
GLYCOMIMETICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	06.01.2012	19.03.2021
GLYCOMIMETICS, INC.	Corporate Officer/Principal	01.01.2006	06.01.2012
Biosynexus, Inc. Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD.	Corporate Officer/Principal	01.01.2001	01.01.2006
National Center for Health Statistics	Corporate Officer/Principal	-	-

Stanford University	Undergraduate Degree
Gw School of Medicine & Health Sciences	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	5
Chief Tech/Sci/R&D Officer	2
Director/Board Member	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
GLYCOMIMETICS, INC.	Health Technology
BIOCRYST PHARMACEUTICALS, INC.	Health Technology
IMMUNOGEN, INC.	Health Technology

Private Unternehmen	3
Biosynexus, Inc. Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD.	Health Technology
Holy Cross Hospital (Maryland)
National Center for Health Statistics	Government